Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of lacidipine in human plasma and its application in a pharmacokinetic study

Journal of Pharmaceutical and Biomedical Analysis

Volumn 47, Issue 4-5, 2008, Pages 923-928

  Tang, Jing ^a   Zhu, Ronghua ^a   Zhao, Ruike ^a   Cheng, Gang ^a   Peng, Wenxing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Determination; Human plasma; Lacidipine; Pharmacokinetics; UPLC ESI MS MS

Indexed keywords

ACETONITRILE; AMMONIUM ACETATE; LACIDIPINE; NIFEDIPINE;

ARTICLE; CALIBRATION; DIAGNOSTIC ACCURACY; DRUG BLOOD LEVEL; DRUG DETERMINATION; ELECTROSPRAY MASS SPECTROMETRY; FLOW RATE; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

ACETATES; ADMINISTRATION, ORAL; BUFFERS; CALCIUM CHANNEL BLOCKERS; CALIBRATION; CHROMATOGRAPHY, LIQUID; CLINICAL TRIALS AS TOPIC; DIHYDROPYRIDINES; DRUG STABILITY; FREEZING; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; METHYL ETHERS; MOLECULAR STRUCTURE; NIFEDIPINE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TABLETS; TANDEM MASS SPECTROMETRY;

EID: 44749087578     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.04.018     Document Type: Article

References (21)

1. Tcherdakoff P. J. Cardiovasc. Pharmacol. 25 (1995) S27-32
2. Lee C.R., and Bryson H.M. Drugs 48 (1994) 274-296
3. McCormack P.L., and Wagstaff A.J. Drugs 63 (2003) 2327-2356
4. Haller H., Cosentino F., and Liischer T.F. Drugs R D 3 (2002) 311-323
5. Toniolo R., Di Narda F., Bontempelli G., et al. Bioelectrochemistry 51 (2000) 193-200
6. Dasgupta A., Jeyaseeli L., Dutta N.K., et al. In Vivo 21 (2007) 847-850
7. Halici Z., Borekci B., Ozdemir Y., et al. Eur. J. Pharmacol. 579 (2008) 241-245
8. United Kingdom Lacidipine Study Group. J. Cardiovasc. Pharmacol. 4 (1991) S27-S30
9. Leonetti G. J. Cardiovasc. Pharmacol. 17 (1991) S31-S34
10. Da Ros L., Squassante L., and Milleri S. Clin. Pharmacokinet. 42 (2003) 99-106
11. Kharat V.R., Verma K.K., and Dhake J.D. J. Pharm. Biomed. Anal. 28 (2002) 789-793
12. López J.A., Martínez V., Alonso R.M., et al. J. Chromatogr. A 870 (2000) 105-114
13. Baranda A.B., Jiménez R.M., and Alonso R.M. J. Chromatogr. A 1031 (2004) 275-280
14. Pellegatti M., Braggio S., Sartori S., et al. J. Chromatogr. 573 (1992) 105-111
15. Braggio S., Sartori S., Angeri F., et al. J. Chromatogr. B Biomed. Appl. 669 (1995) 383-389
16. Baranda A.B., Etxebarria N., Jiménez R.M., et al. J. Chromatogr. Sci. 43 (2005) 505-512
17. Ramakrishna N.V.S., Vishwottam K.N., Puran S., et al. J. Mass Spectrom. 39 (2004) 824-832
18. Baranda A.B., Mueller C.A., Alonso R.M., et al. Ther. Drug Monit. 27 (2005) 44-52
19. International conference on Harmonization, Draft Guideline on Validation Procedurres Definitions and Terminology, Federal Register, vol. 60, IFPMA, Switzerland, 1995, p. 11260.
20. USFDA, 2001, http://www.fda.gov/cder/guidance/4252fnl.htm.
21. SFDA, 2005, http://www.sda.gov.cn/gsz05106/08.pdf.